Article Versions Notes

Gupte M, Umbarkar P, Singh AP, Zhang Q, Tousif S, Lal H. Deletion of Cardiomyocyte Glycogen Synthase Kinase-3 Beta (GSK-3β) Improves Systemic Glucose Tolerance with Maintained Heart Function in Established Obesity. Cells. 2020; 9(5):1120. https://doi.org/10.3390/cells9051120

Gupte, Manisha, Prachi Umbarkar, Anand Prakash Singh, Qinkun Zhang, Sultan Tousif, and Hind Lal. 2020. "Deletion of Cardiomyocyte Glycogen Synthase Kinase-3 Beta (GSK-3β) Improves Systemic Glucose Tolerance with Maintained Heart Function in Established Obesity" Cells 9, no. 5: 1120. https://doi.org/10.3390/cells9051120

Gupte, M., Umbarkar, P., Singh, A. P., Zhang, Q., Tousif, S., & Lal, H. (2020). Deletion of Cardiomyocyte Glycogen Synthase Kinase-3 Beta (GSK-3β) Improves Systemic Glucose Tolerance with Maintained Heart Function in Established Obesity. Cells, 9(5), 1120. https://doi.org/10.3390/cells9051120